SPARCL1 and atherosclerosis: Endothelial dysfunction is a critical initiating factor in atherosclerosis, and the role of SPARCL1 in stabilizing the vascular endothelium [34], along with its confirmed involvement in atherosclerosis development [35], suggests its potential as a therapeutic target for the disease.